U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Monday.
Shares of BioAge Labs, Inc. BIOA fell sharply in today's pre-market trading after the company announced discontinuation of STRIDES Phase 2 clinical trial evaluating Azelaprag in combination with Tirzepatide for the treatment of obesity.
BioAge Labs shares tumbled 68.6% to $6.30 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- Palmer Square Capital BDC Inc PSBD shares tumbled 18.3% to $13.00 in pre-market trading.
- Bicara Therapeutics Inc BCAX fell 14.7% to $18.00 in pre-market trading after gaining 8% on Friday.
- ZJK Industrial Co Ltd ZJK fell 10.9% to $12.55 in pre-market trading.
- Heritage Commerce Corp. HTBK declined 9.7% to $9.50 in pre-market trading.
- Bel Fuse Inc BELFB declined 7.1% to $78.00 in pre-market trading.
- Riot Platforms Inc RIOT fell 6.7% to $12.08 in pre-market trading. Riot Platforms announced a proposed private offering of $500 million of convertible senior notes.
- ZimVie Inc ZIMV fell 6.5% to $13.03 in pre-market trading.
- AppLovin Corporation APP declined 5.8% to $378.00 in pre-market trading after gaining around 6% on Friday.
Now Read This:
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in